Potassium citrate
Potassium Citrate is a prescription medication used to treat and prevent kidney stones by making urine less acidic. It comes as extended-release oral tablets in 10 mEq and 15 mEq strengths, manufactured by ANI Pharmaceuticals, Inc. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Potassium Citrate is a prescription medication used to treat and prevent kidney stones by making urine less acidic. It comes as extended-release oral tablets in 10 mEq and 15 mEq strengths, manufactured by ANI Pharmaceuticals, Inc. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Potassium citrate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Potassium citrate — ANDA 212779 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212779"
}
]
|
| identifier | ANDA212779 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"health-care",
"medications",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Potassium citrate |
